| 产品名称 | TG 101348 - Fedratinib | SAR 302503 |
| 产品货号 | Axon 1588 CAS [936091-26-8] MF C27H36N6O3SMW 524.68 Purity: 99% Soluble in DMSO Description An orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 (JAK2, IC50: ca 3 nM) with potential antineoplastic activity. KEYWORDS: TG 101348 | supplier | JAK2 inhibitor | Fedratinib | SAR 302503 | TG101348 | SAR302503 | TG-101348 | SAR-302503 | CAS [936091-26-8] | JAK-STAT Pathway | Janus-associated kinase | antineoplastic | hematopoietic stem cell | HSC |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
TG 101348 - Fedratinib | SAR 302503Axon 1588 CAS [936091-26-8] MF C27H36N6O3S
DescriptionAn orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 (JAK2, IC50: ca 3 nM) with potential antineoplastic activity. KEYWORDS: TG 101348 | supplier | JAK2 inhibitor | Fedratinib | SAR 302503 | TG101348 | SAR302503 | TG-101348 | SAR-302503 | CAS [936091-26-8] | JAK-STAT Pathway | Janus-associated kinase | antineoplastic | hematopoietic stem cell | HSC
List of publications using TG 101348 (Axon 1588) purchased from Axon Medchem
JAK2 inhibitor
Chemical nameN-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide Parent CAS No.[936091-26-8] |
| 产品资料 |
